Authors
Latest:
Specialty Pharmacy By the NumbersAs specialty pharmacies continue to grow, health systems will need to evaluate whether an integrated specialty pharmacy is right for them.
Latest:
Rx Product News Profile: A Closer Look at New FDA Actions: Bristol-Myers Squibb's and AstraZeneca's OnglyzaOnglyza (saxagliptin) comarketed by Bristol-Myers Squibb and AstraZeneca, is FDA-approved to improve glycemic control for the treatment of type 2 diabetes.
Latest:
Pharmacists Need to Understand Law Related to Controlled SubstancesThe Protecting Patient Access to Emergency Medications Act of 2017 Spells Out Appropriate Dispensing Procedures.
Latest:
Many Platforms Offer Rapid Detection in Bloodstream InfectionsInstitutions should consider optimal targets, testing volumes, and notification and reporting practices when making their choice.
Latest:
Inconsistent Prior Authorization Affects Attention-Deficit/Hyperactivity Disorder TreatmentStudy finds that ADHD treatment recommendations are not always followed.
Latest:
Pharmacogenetic Resources: PharmGKB and Clinical Pharmacogenetics Implementation ConsortiumPharmacogenetics is the study of how genes impact drug response, an integral part of personalized medicine.
Latest:
Potential Gender Differences of Exenatide in Outpatients With Type 2 Diabetes MellitusIn outpatients with type 2 diabetes mellitus, persistent exenatide treatment lowered glycated hemoglobin and hyperglycemia in both genders. Waist circumference and body weight were more reduced in women.
Latest:
Zuranolone Offers An Innovative Treatment for Postpartum DepressionZuranolone enhances health care providers’ ability to address the complex needs of patients with PPD, offering new hope for rapid and sustained relief from depressive symptoms.
Latest:
Impact of Specialty Pharmacy on Treatment Costs for Rheumatoid ArthritisFor patients who use biologic treatments for rheumatoid arthritis, specialty pharmacy care yields higher medication adherence and lower medical costs than retail pharmacy care.
Latest:
Economic Burden of Oral Tyrosine Kinase Inhibitors Among Privately Insured Patients Diagnosed With Metastatic Renal Cell CarcinomaStudy investigate the economic burden from the total costs, private insurance reimbursement, and out-of-pocket costs for oral TKI agents among metastatic RCC patients.
Latest:
Estrogens and Lamotrigine: New DevelopmentsPractitioners have known for almost 2 decades that oral contraceptives consistently and substantially reduce the serum concentrations of lamotrigine and may reduce seizure control.
Latest:
Treatments for Tardive Dyskinesia: What Pharmacists Should KnowThere are two recently approved medications for this condition.
Latest:
Effect of Dispensing Supply on Pravastatin Refill AdherenceIn uninsured, indigent, and low-income patients with hyperlipidemia, optimum pravastatin refill adherence was observed with a 90-day dispensing supply.
Latest:
Cost of Dispensing Specialty Drugs May Be More Than You ThinkSmaller entrepreneurial pharmacy owners are proactively pursuing the dispensing of specialty medications.
Latest:
Complete Immunization Services Start With Gathering Patient InformationPharmacy team members have the amazing opportunity to help ensure that people and communities are protected with proper immunizations during influenza (flu) season and beyond, but they may struggle with identifying patients who may benefit because it can be difficult to gather information from patients.
Latest:
HOPA 2021: New Therapies on the Horizon for Advanced NSCLCA session at the Hematology/Oncology Pharmacy Association Virtual Annual Conference provided an overview of how treatment options are changing with potential new therapies in development for patients with non-small cell lung cancer.
Latest:
Understanding the Evolving Landscape of Malignant MelanomaThis Continuing Education activity is supported by an educational grant from Merck Sharpe & Dohme Corp.
Latest:
Could Zinc Supplements Help Prevent Febrile Seizures?Some evidence suggests that a febrile seizure occurs when the child has low serum zinc levels.
Latest:
New Insulin Products and Best PracticesEven with many new developments over the past century, the coordinated use of blood glucose monitors, diabetes medications, and insulin to manage the disease may be too intricate for some patients.
Latest:
Cost Impact of Switching From Metoprolol to Nebivolol for HypertensionA large single-payer administrative claims database was used to assess the economic impact of switching from metoprolol to nebivolol for the treatment of hypertension.
Latest:
Medicare Plans Face New Oversight and Scrutiny From Audit ChangesThe 2015 Medicare Part D audit protocols add a layer of complexity to Part D plans and increase their probability of receiving mandatory corrective actions.
Latest:
Modeled Cost Differences Associated With Use of Levonorgestrel Intrauterine DevicesThis analytic model assessed the per-woman cost differences between the use of 2 levonorgestrel-releasing intrauterine devices, from a US payer perspective.
Latest:
Latent Tuberculosis After the Use of EtanerceptTNF-alpha inhibitors are used to treat a number of inflammatory conditions.
Latest:
Bringing Students and Faculty Together Over TeaAlthough pharmacy schools are known for their advancements in pharmacy education, scientific discovery, and patient care, they still face an unspoken and universal truth shared among institutions of higher learning: students sometimes feel lost and unsure of themselves, and as if they have no one to whom they can turn.
Latest:
Impact of Patient Cost Sharing on Multiple Sclerosis TreatmentThis study evaluates the impact of patient cost sharing on the probability of receiving disease-modifying therapies and treatment compliance among patients with multiple sclerosis.
